2021 Revenues ($USD) : $2,537,156,000
2021 R&D spend : $119,747,000
2021 Number of Employees : 14,000
Fiscal Year End : 12/31/2020
Key People : Liam Kelly, chair, president and CEO; Thomas Powell, EVP and CFO; Petro Barchuk, VP, financial planning and analysis; Karen Boylan, CVP, strategic projects; John Deren, CVP and chief accounting officer; Michael DiGiuseppe, president, Latin America and Americas commercial operations group; Timothy Duffy, VP and chief information officer; James Ferguson, president and GM, surgical; Michelle Fox, SVP and chief medical officer; Sunny Goh, president, APAC; Kevin Hardage, president and GM, interventional urology; Marie Hendrixson, VP, internal audit; Cameron Hicks, CVP and chief human resources officer; Matthew James, president, EMEA and global urology; Lawrence Keusch, VP, investor relations and strategy development; Michael Kryukov, VP, global tax; Lisa Kudlacz, president and GM, vascular; Bert Lane, VP, global logistics and distribution; Daniel Logue, CVP, general counsel and secretary; Justin McMurray, VP, global strategic R&D; Jake Newman, group president; Daniel Price, VP, commercial finance; Kevin Robinson, VP and GM, anesthesia and emergency medicine; Greg Stotts, VP and GM, OEM; Ed Weidner, VP, customer experience and commercial operations; Jay White, CVP and president, global commercial; James Winters, CVP, manufacturing and supply chain.

About the company: The Wayne, Pennsylvania–based critical care and surgical tech company boasts a diverse portfolio serving the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Its notable brands include Arrow, Deknatel, Hudson RCI, LMA, Pilling, Rüsch, UroLift and Weck.  –CN